Allergy and Asthma: Small molecule approaches

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Current therapies for asthma and allergy are aimed at controlling disease symptoms. For most asthmatics, inhaled anti-inflammatory therapy is effective, but a subset of patients remains symptomatic despite optimal treatment creating a clear unmet medical need. Although considered a less-serious condition than asthma, allergic diseases are common and considerably impact on the quality of life of affected individuals. Innovative disease-modifying therapeutics are needed for both allergy and asthma. Biopharmaceutical approaches may identify small molecules that target key cells and mediators that drive the inflammatory responses that underlie the pathogenesis of allergy and asthma.
Original languageEnglish
Title of host publicationWiley Encyclopaedia of Chemical Biology
EditorsT.P. Begley
PublisherWiley-Blackwell
Pages1-8
Number of pages8
ISBN (Electronic)978-0470048672
ISBN (Print)0471754773, 978-0471754770
DOIs
Publication statusPublished - 29 Jan 2008

Fingerprint

Hypersensitivity
Asthma
Therapeutics
Anti-Inflammatory Agents
Quality of Life

Cite this

Walsh, G. M. (2008). Allergy and Asthma: Small molecule approaches. In T. P. Begley (Ed.), Wiley Encyclopaedia of Chemical Biology (pp. 1-8). Wiley-Blackwell . https://doi.org/10.1002/9780470048672.wecb676

Allergy and Asthma : Small molecule approaches. / Walsh, Garry Michael.

Wiley Encyclopaedia of Chemical Biology . ed. / T.P. Begley. Wiley-Blackwell , 2008. p. 1-8.

Research output: Chapter in Book/Report/Conference proceedingChapter

Walsh, GM 2008, Allergy and Asthma: Small molecule approaches. in TP Begley (ed.), Wiley Encyclopaedia of Chemical Biology . Wiley-Blackwell , pp. 1-8. https://doi.org/10.1002/9780470048672.wecb676
Walsh GM. Allergy and Asthma: Small molecule approaches. In Begley TP, editor, Wiley Encyclopaedia of Chemical Biology . Wiley-Blackwell . 2008. p. 1-8 https://doi.org/10.1002/9780470048672.wecb676
Walsh, Garry Michael. / Allergy and Asthma : Small molecule approaches. Wiley Encyclopaedia of Chemical Biology . editor / T.P. Begley. Wiley-Blackwell , 2008. pp. 1-8
@inbook{48c94419dd094c5b9d2e0eefe04a6177,
title = "Allergy and Asthma: Small molecule approaches",
abstract = "Current therapies for asthma and allergy are aimed at controlling disease symptoms. For most asthmatics, inhaled anti-inflammatory therapy is effective, but a subset of patients remains symptomatic despite optimal treatment creating a clear unmet medical need. Although considered a less-serious condition than asthma, allergic diseases are common and considerably impact on the quality of life of affected individuals. Innovative disease-modifying therapeutics are needed for both allergy and asthma. Biopharmaceutical approaches may identify small molecules that target key cells and mediators that drive the inflammatory responses that underlie the pathogenesis of allergy and asthma.",
author = "Walsh, {Garry Michael}",
year = "2008",
month = "1",
day = "29",
doi = "10.1002/9780470048672.wecb676",
language = "English",
isbn = "0471754773",
pages = "1--8",
editor = "T.P. Begley",
booktitle = "Wiley Encyclopaedia of Chemical Biology",
publisher = "Wiley-Blackwell",

}

TY - CHAP

T1 - Allergy and Asthma

T2 - Small molecule approaches

AU - Walsh, Garry Michael

PY - 2008/1/29

Y1 - 2008/1/29

N2 - Current therapies for asthma and allergy are aimed at controlling disease symptoms. For most asthmatics, inhaled anti-inflammatory therapy is effective, but a subset of patients remains symptomatic despite optimal treatment creating a clear unmet medical need. Although considered a less-serious condition than asthma, allergic diseases are common and considerably impact on the quality of life of affected individuals. Innovative disease-modifying therapeutics are needed for both allergy and asthma. Biopharmaceutical approaches may identify small molecules that target key cells and mediators that drive the inflammatory responses that underlie the pathogenesis of allergy and asthma.

AB - Current therapies for asthma and allergy are aimed at controlling disease symptoms. For most asthmatics, inhaled anti-inflammatory therapy is effective, but a subset of patients remains symptomatic despite optimal treatment creating a clear unmet medical need. Although considered a less-serious condition than asthma, allergic diseases are common and considerably impact on the quality of life of affected individuals. Innovative disease-modifying therapeutics are needed for both allergy and asthma. Biopharmaceutical approaches may identify small molecules that target key cells and mediators that drive the inflammatory responses that underlie the pathogenesis of allergy and asthma.

U2 - 10.1002/9780470048672.wecb676

DO - 10.1002/9780470048672.wecb676

M3 - Chapter

SN - 0471754773

SN - 978-0471754770

SP - 1

EP - 8

BT - Wiley Encyclopaedia of Chemical Biology

A2 - Begley, T.P.

PB - Wiley-Blackwell

ER -